Drug Profile
CBT 125
Alternative Names: CBT-125Latest Information Update: 29 Aug 2016
Price :
$50
*
At a glance
- Originator Cipla BioTec
- Class Peptide hormones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Diabetes insipidus; Diabetes mellitus
Most Recent Events
- 30 Apr 2016 Registered for Diabetes insipidus in India (unspecified route) before April 2016
- 30 Apr 2016 Registered for Diabetes mellitus in India (unspecified route) before April 2016